IC
Ikarian Capital Portfolio holdings
AUM
$302M
1-Year Return
65.21%
This Quarter Return
+43.34%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$350M
AUM Growth
+$28.2M
(+8.8%)
Cap. Flow
+$25.7M
Cap. Flow
% of AUM
7.33%
Top 10 Holdings %
Top 10 Hldgs %
41.9%
Holding
166
New
42
Increased
23
Reduced
56
Closed
16
Top Buys
| 1 |
Scholar Rock
SRRK
|
$15.4M |
| 2 |
Forte Biosciences
FBRX
|
$13.8M |
| 3 |
TG Therapeutics
TGTX
|
$8.77M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$7.36M |
| 5 |
Vir Biotechnology
VIR
|
$6.59M |
Top Sells
| 1 |
Tarsus Pharmaceuticals
TARS
|
$23.4M |
| 2 |
Soleno Therapeutics
SLNO
|
$11.2M |
| 3 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$5.76M |
| 4 |
Arcus Biosciences
RCUS
|
$5.44M |
| 5 |
Capricor Therapeutics
CAPR
|
$4.56M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
